Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints
Source: Journal of Cardiovascular Magnetic Resonance
Costs and Healthcare Utilization of Heart Disease by COVID-19 Diagnosis and Race and Ethnicity
Source: AJPM Focus
The relationship between microRNAs and COVID-19 complications
Source: Non-coding RNA Research
Determinants of cardiovascular health indices among physicians in a tertiary centre
Source: Current problems in cardiology
Etiology of Severe Acute Respiratory Infections in ICU-Admitted Patients During the COVID-19 Pandemic in Iran: A Single Center Study
Source: Archives of Pediatric Infectious Diseases
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
